Graham Lumsden, chief executive of Motif Bio Plc (LON:MTFB), caught up with Proactive's Andrew Scott following the news that three iclaprim abstracts have been accepted for presentation at the upcoming 28th European Congress of Clinical Microbiology and Infectious Diseases in Madrid this April.
ECCMID brings together leading experts in the infectious diseases, infection control and clinical microbiology sectors.
Lumsden says it's an important arena to showcase Motif Bio's iclaprim data.
Meet Medusa Mining, Cora Gold, Group Eleven Resources Ltd., Harvest Minerals Ltd. and Crusader Resources Ltd at our event, London, 22 February 2018.Register here >>